Argentina vs Costa Rica: Previously treated cases tested for RR-/MDR-TB
Argentina
61.0%
in 2024
Costa Rica
62.0%
in 2024
Argentina rank
136th
Costa Rica rank
135th
Previously treated cases tested for RR-/MDR-TB over time
- Argentina
- Costa Rica
How they compare
Costa Rica currently reports 62.0% against 61.0% in Argentina, a difference of 1.0%.
The two have swapped places 7 times across 13 shared years of data; in 2005 it was Argentina ahead.
Argentina ranks 136th and Costa Rica ranks 135th of 180 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Costa Rica in 2.
Head to head by decade
| Decade | Argentina | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 2.2% | 97.8% | Argentina |
| 2010s | 31.3% | 31.7% | 0.4% | Costa Rica |
| 2020s | 52.0% | 54.8% | 2.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Argentina or Costa Rica?
- Costa Rica, at 62.0% against 61.0% in Argentina as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Argentina and Costa Rica?
- 1.0%, with Costa Rica ahead.
- How many years of comparable data are there for Argentina and Costa Rica?
- 13 years are reported by both, from 2005 to 2024.
- How do Argentina and Costa Rica rank globally for previously treated cases tested for rr-/mdr-tb?
- Argentina ranks 136th and Costa Rica ranks 135th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.